2023 annual financial data
Inovio Pharmaceuticals 2023 Net margin
Direct answer
Net margin was -16,239.87%.
Operating income was -143,940,028 USD and net income was -135,117,352 USD.
Operating cash flow was -124,365,551 USD.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 832,010 USD
- Operating income
- -143,940,028 USD
- Net income
- -135,117,352 USD
- Operating cash flow
- -124,365,551 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Inovio Pharmaceuticals financial years